Pure Global AI
NCT06362499Recruiting

Effects of Unsupervised Inspiratory Muscle Training on Ventilation Variability in Post-covid-19 Patients.

Effects of Unsupervised Inspiratory Muscle Training on Ventilation Variability in Post-covid-19 Patients: Protocol for Randomized Clinical Trial.
Universidade Federal do Rio Grande do NorteClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
COVID-19
Drug/Device/Intervention
Experimental Group
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Universidade Federal do Rio Grande do Norte
Location
Natal,Natal, Brazil
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jul 31, 2024
Enrollment
24 participants
Primary outcome

Ventilation variability and ventilation efficiency

Summary

Dysfunctional breathing and persistent hypocapnia can be associated with many of the symptoms
 experienced by patients such as dyspnea, fatigue, chest pain and palpitations. The
 identification of dysfunctional breathing and hypocapnia in these patients is important as it
 may represent a target for treatment.
 
 In many of these patients, tachypnea at low levels of exertion suggests increased respiratory
 muscle activity, which can lead to the sensation of dyspnea. Sympathetic hyperactivity leads
 to excessive and irregular ventilation during exercise. In this way, inspiratory muscle
 training can improve symptoms (dysfunctional breathing), possibly by attenuating the
 metaboreflex (vagal modulation-attenuation of the sympathetic response) of the inspiratory
 muscle in post-covid-19 subjects, reducing ventilatory variability.

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteViral infection, unspecifiedRift Valley fever
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06362499
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06362499 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Federal do Rio Grande do Norte and is currently Recruiting. The study focuses on COVID-19. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.